These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 15702784

  • 1. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR, Liu T, Meng WT, Yu J, Niu T.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [Abstract] [Full Text] [Related]

  • 2. Angiogenesis in myelodysplastic syndromes.
    Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F.
    Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
    [Abstract] [Full Text] [Related]

  • 3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 4. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E, Korkolopoulou P, Androulaki A, Douzinas E, Kosmopoulou O, Kordossis T.
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [Abstract] [Full Text] [Related]

  • 7. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG, Passam FH, Pappa CA, Sfiridaki K, Tsirakis G, Damilakis J, Stathopoulos EN, Kyriakou DS.
    Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
    [Abstract] [Full Text] [Related]

  • 8. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY, Li X, Chang CK, Ying SX, Pu Q.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R.
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS, Kumar L, Dinda AK, Dawar R.
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W, Hattori Y, Hashiguchi A, Kondoh K, Hozumi N, Ikeda Y, Sakamoto M, Hata J, Yamada T.
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [Abstract] [Full Text] [Related]

  • 17. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
    Zhang JQ, Wang JK, Li YM.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
    [Abstract] [Full Text] [Related]

  • 18. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY, Tien HF, Hu CY, Chou WC, Lin LI.
    Br J Cancer; 2007 Oct 08; 97(7):877-82. PubMed ID: 17848952
    [Abstract] [Full Text] [Related]

  • 19. VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Gianelli U, Vener C, Raviele PR, Savi F, Somalvico F, Calori R, Iurlo A, Radaelli F, Fermo E, Bucciarelli P, Bori S, Coggi G, Deliliers GL.
    Am J Clin Pathol; 2007 Dec 08; 128(6):966-73. PubMed ID: 18024322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.